The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mccamish Mark Anthony since 2018.
This trader's CIK number is 1390798.
At the time of last reporting, Mccamish Mark Anthony was the Officer of Avadel Pharmaceuticals Plc. (stock ticker symbol AVDL).
Also see all insider trading activities at Avadel Pharmaceuticals Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | AVDL | 0 | $0 | 103,975 | $1,522,375 | 0 | $0 |
| 2020 | AVDL | 171,000 | $985,215 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | FTSV | 0 | $0 | 32,577 | $3,108,399 | 30,237 | $147,647 |
| 2019 | FTSV | 0 | $0 | 102,500 | $1,522,105 | 154,187 | $752,891 |
| 2018 | FTSV | 0 | $0 | 12,000 | $190,764 | 12,000 | $58,596 |
1. Avadel Pharmaceuticals Plc (AVDL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-28 | AVDL | Sale | 75,000 | 14.53 | 1,089,750 |
| 2023-08-11 | AVDL | Sale | 28,975 | 14.93 | 432,625 |
| 2020-09-16 | AVDL | Buy | 118,602 | 5.73 | 679,945 |
| 2020-09-17 | AVDL | Buy | 52,398 | 5.83 | 305,270 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-01 | FTSV | Option Ex | 30,237 | 4.88 | 147,647 |
| 2020-04-01 | FTSV | Sale | 32,577 | 95.42 | 3,108,399 |
| 2019-06-25 | FTSV | Sale | 8,199 | 11.03 | 90,393 |
| 2019-06-25 | FTSV | Option Ex | 8,199 | 4.88 | 40,035 |
| 2019-06-20 | FTSV | Option Ex | 8,301 | 4.88 | 40,533 |
| 2019-06-20 | FTSV | Sale | 8,301 | 11.04 | 91,626 |
| 2019-05-20 | FTSV | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-05-20 | FTSV | Sale | 16,500 | 12.27 | 202,372 |
| 2019-04-18 | FTSV | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-04-18 | FTSV | Sale | 16,500 | 18.12 | 299,062 |
| 2019-03-19 | FTSV | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-03-19 | FTSV | Sale | 16,500 | 18.15 | 299,409 |
| 2019-02-20 | FTSV | Sale | 9,410 | 14.94 | 140,547 |
| 2019-02-19 | FTSV | Sale | 7,090 | 15.06 | 106,796 |
| 2019-02-20 | FTSV | Option Ex | 9,410 | 4.88 | 45,949 |
| 2019-02-19 | FTSV | Option Ex | 7,090 | 4.88 | 34,620 |
| 2019-01-25 | FTSV | Option Ex | 51,687 | 4.88 | 252,387 |
| 2019-01-18 | FTSV | Sale | 20,000 | 14.60 | 291,900 |
| 2019-01-18 | FTSV | Option Ex | 20,000 | 4.88 | 97,660 |
| 2018-12-26 | FTSV | Option Ex | 12,000 | 4.88 | 58,596 |
| 2018-12-26 | FTSV | Sale | 12,000 | 15.90 | 190,764 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccamish Mark Anthony (Officer of Avadel Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.